SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001047469-98-011749
Filing Date
1998-03-26
Accepted
1998-03-26 00:00:00
Documents
12
SROs
NYSE

Document Format Files

Seq Description Document Type Size
1 SC 13D SC 13D 85265
2 ACQUISITION AGREEMENT EX-99.(A)(1) 170307
3 CONFIDENTIALITY AGREEMENT EX-99.(A)(2) 22971
4 SHRHLDR AGREEMENT W/DEBARTOLO JR EX-99.(A)(3) 7507
5 SHRHLDR AGREEMENT W/DEBARTOLO SR EX-99.(A)(4) 7738
6 SHRHLDR AGREEMENT W/NOTRE DAME EX-99.(A)(5) 7663
7 SHRHLDR AGREEMENT W/CUSICK EX-99.(A)(6) 7272
8 SHRHLDR AGREEMENT W/WARREN EX-99.(A)(7) 7283
9 SHRHLDR AGREEMENT FROM CITINVEST EX-99.(A)(8) 781
10 SHRHLDR LETTER FROM ORACLE EX-99.(A)(9) 797
11 AMENDMENT TO RIGHTS AGREEMENT EX-99.(A)(10) 3426
12 JOINT FILING AGREEMENT EX-99.(A)(11) 1492
  Complete submission text file 0001047469-98-011749.txt   325726
Mailing Address
Business Address 100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK IL 60064-3500 (708)-937-61
ABBOTT LABORATORIES (Filed by) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2255 B QUEEN STREET EAST SUITE 828 TORONTO ONTARIO A6
Business Address 2255 B QUEEN STREET EAST SUITE 828 TORONTO ONTARIO A6 5198368016
INTERNATIONAL MUREX TECHNOLOGIES CORP (Subject) CIK: 0000864964 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-41252 | Film No.: 98574722
SIC: 2835 In Vitro & In Vivo Diagnostic Substances